Conversations as a Means to Delay the Onset of Alzheimer's Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Mild Cognitive ImpairmentCognitive Change
Interventions
BEHAVIORAL

Active social engagement group

Engage in 30 minutes conversation daily using internet/webcam, 5 days per week for 6 weeks, tracking of daily conversational amount outside of the trial by using a digital recording device, lasting effects will be assessed at the 3rd and 6th month after completion of the intervention

BEHAVIORAL

Control group

No active intervention, weekly phone calls by interviewer to complete health/social engagement monitoring survey, tracking of daily conversational amount by using a digital recording device. Participants will be reassessed at the 3rd and 6th month after completion of the intervention.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Oregon Health and Science University

OTHER

NCT01571427 - Conversations as a Means to Delay the Onset of Alzheimer's Disease | Biotech Hunter | Biotech Hunter